Palatin Technologies
PTN
#10059
Rank
A$41.62 M
Marketcap
A$24.45
Share price
6.32%
Change (1 day)
1,475.88%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -A$7.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$8.84 Million. In 2024 the company made an earning of -A$40.33 Million, an increase over its 2023 earnings that were of -A$48.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$7.94 Million-80.33%
2024 -A$40.33 Million-16.9%
2023 -A$48.53 Million5.99%
2022 -A$45.79 Million-13.7%
2021 -A$53.06 Million33.25%
2020 -A$39.82 Million-172.11%
2019 A$55.2 M2352.33%
2018 A$2.25 M-94.13%
2017 A$38.36 M-154.92%
2016 -A$69.85 Million3.67%
2015 -A$67.38 Million878%
2014 -A$6.89 Million-72.64%
2013 -A$25.18 Million-33.11%
2012 -A$37.65 Million77.71%
2011 -A$21.19 Million
2003 -A$35.87 Million29.93%
2002 -A$27.61 Million36.18%
2001 -A$20.28 Million
1999 -A$16.83 Million6.04%
1998 -A$15.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-A$17.97 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$44.14 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.87 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$75.66 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$99.98 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.49 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$83.16 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.59 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK